Relatório global de análise do tamanho, quota e tendências do mercado de instrumentos de cirurgia cardíaca – visão geral do setor e previsão para 2031

Análise do mercado de instrumentos de cirurgia cardíaca

As principais causas de doenças cardíacas em pessoas de todo o mundo são o consumo de junk food, o sedentarismo e o stress mental. De acordo com a OMS, aproximadamente 17,9 milhões de pessoas morrem de doenças cardiovasculares todos os anos, o que representa aproximadamente 31,0% de todas as mortes em todo o mundo. Prevê-se que cerca de 23,6 milhões de pessoas morram de doenças cardiovasculares até 2030. Além disso, o tabagismo e o consumo de tabaco podem ser responsáveis ​​por um número significativo destas mortes.

Tamanho do mercado de instrumentos de cirurgia cardíaca

O tamanho do mercado global de instrumentos de cirurgia cardíaca foi avaliado em 1,96 mil milhões de dólares em 2023 e deverá atingir os 2,58 mil milhões de dólares até 2031, com um CAGR de 3,50% durante o período de previsão de 2024 a 2031 .

Âmbito do relatório e segmentação de mercado       

Cardiac Surgery Instruments Market Definition

Cardiac surgery is surgery performed on the heart or large vessels by cardiac surgeons. The surgery also necessitates a heart transplant. For any procedure, three types of surgical instruments are typically used. Needles, scissors, retractors, peripheral vascular, aorta, and anastomosis clamps, paediatric instruments, titanium micro instruments, and other instruments are among those available.

Cardiac surgery instruments Market Dynamics

Drivers

• The rise in the cases of cardiovascular diseases around the world

The rise in the prevalence of Cardiovascular Diseases (CVDs) around the world is one of the major factors driving the growth of the cardiac surgery instruments market. The introduction of technologically advanced pacemakers, such as leadless pacemakers and MRI safe pacemakers, as well as favourable government policies, propels the market forward.

The advancement in medical products in healthcare sector

Growing adoption of advanced medical products and improvements in the healthcare sector, as well as a rising number of technological advancements, will all contribute to the growth of the cardiac surgery instruments market over the forecasted timeframe.

• Government investments for healthcare interoperability

The increase in the funding by the federal government to drive the adoption of these solutions further influence the market. Additionally, the surge in healthcare expenditure, advancements in healthcare infrastructure, and high demand for expanded care delivery positively affect the cardiac surgery instruments market.

Opportunities

The rising number of patients suffering from cardiac disorders, the rising number of surgical procedures, the rising prevalence of geriatric population around the world, the rising level of investment for the growth of the healthcare sector, the rising prevalence of favourable government policies, sedentary lifestyle, junk food consumption, and mental stress are some of the major and vital factors that will likely augment the growth of the cardiac surgery instruments market..

Restraints/Challenges

Increasing adoption of alternative surgical methods, as well as a scarcity of professional cardiac surgeons, will likely act as market restraints for the growth of cardiac surgery instruments over the forecasted timeframe. Stringent government regulation of medical devices, as well as price caps for medical devices, will be the biggest and most pressing challenge to the market's growth.

This cardiac surgery instruments market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the cardiac surgery instruments market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Cardiac Surgery Instruments Market

The COVID-19 pandemic is expected to have a negative impact on the growth of the cardiac pacemaker market. Many countries have suffered and continue to bear a significant burden on both their economies and healthcare systems as a result of the high transmission rate and lack of treatment. Many countries have gone into lockdown, suspending trade with other countries, imposing travel restrictions, and so on, resulting in a drop in the market capitalizations of major companies around the world.

Cardiac Surgery Instruments Market Scope

The cardiac surgery instruments market is segmented on the basis of instrument type, sales channel, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Instrument Type

• Forceps
• Scissors
• Clamps and dilators
• Needle holders and needle
• Retractors and rongeurs
• others

Based on instrument type, the cardiac surgery instruments market is segmented into forceps, scissors, clamps and dilators, needle holders and needles, retractors and rongeurs, and others. Forceps have been further segmented into vascular forceps, grasping forceps, and other forceps.

Sales channel

• Online retailing
• Offline retailing

Based on sales channel, the cardiac surgery instruments market is segmented into online retailing, and offline retailing.

Application

• Coronary artery bypass grafting
• Heart valve repair and replacement
• Implantable cardioverter defibrillator
• Paediatric cardiac surgery
• Heart transplant
• Others

On the basis of application, the cardiac surgery instruments market is segmented into coronary artery bypass grafting (CABG), heart valve repair and replacement, implantable cardioverter defibrillator (ICD), paediatric cardiac surgery, heart transplant, and others.

End User

• Cardiac centres
• Ambulatory surgical centres
• Hospitals
• Clinics

Cardiac surgery instruments market has also been segmented based on the end user into hospitals, cardiac clinics, ambulatory surgery centres, and others.

Cardiac Surgery Instruments Market Regional Analysis

The cardiac surgery instruments market is analysed and market size insights and trends are provided by country, instrument type, sales channel, application and end users as referenced above.

The countries covered in the cardiac surgery instruments market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the cardiac surgery instruments market due to the increasing prevalence of cardiac disorders as well as the increasing adoption of advanced tools and devices for surgeries in the region, whereas Asia-Pacific is expected to grow at the fastest rate during the forecast period due to the region's increasing geriatric population as well as the rising number of cardiac surgeries.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The cardiac surgery instruments market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for cardiac surgery instruments market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the cardiac surgery instruments market. The data is available for historic period 2010-2020.

Cardiac Surgery Instruments Market Share

The cardiac surgery instruments market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to cardiac surgery instruments market.

Os líderes de mercado de Instrumentos de Cirurgia Cardíaca que operam no mercado são:

• ESTÉRIS. (NÓS)
• Steelco SpA (Itália)
• Schülke & Mayr GmbH (Alemanha)
• Adriça O&M (EUA)
• Grupo de Empresas Bergen (Índia)
• Ecolab (EUA)
• Tristel (EUA)
• Belimed (Suíça)
• ASP (EUA)
• Getinge AB. (Suécia)
• JAYCO, INC.
• Grupo MMM (Alemanha)
• GRUPO MATACHANA (Espanha)
• Huaiyin Medical Instruments Co., Ltd (China)
• TSO3 (Canadá)
• SAKURA SI CO., LTD. (Japão)
• Crest Ultrasonics Corporation (China)
• (EUA).

Últimos desenvolvimentos no mercado de instrumentos de cirurgia cardíaca

• A Medtronic Private Limited vai lançar a tecnologia Azure Pacemaker BlueSync na Índia em outubro de 2020. Esta tecnologia pode comunicar diretamente com os smartphones e tablets dos pacientes
• A Medtronic PLC recebeu a aprovação da FDA dos EUA para o seu Leadless Micra AV, o pacemaker mais pequeno do mundo com sincronia auriculoventricular (AV), em fevereiro de 2020

SKU-10020